Structure of the A20 OTU domain and mechanistic insights into deubiquitination

被引:136
作者
Komander, David [1 ]
Barford, David [1 ]
机构
[1] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England
关键词
A20 binding inhibitor of NF-kappa B (ABIN); cytokine signalling; deubiquitinating enzyme; inhibitor of kappa B kinase (IKK); Lys(63)-linked ubiquitin; nuclear factor kappa B (NF-kappa B); TGF (transforming growth factor)-beta-activated kinase (TAK1); tumour-necrosis-factor-receptor-associated factor (TRAF);
D O I
10.1042/BJ20071399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NF-kappa B (nuclear factor kappa B) regulator A20 antagonises IKK [I kappa B (inhibitor of kappa B) kinase] activation by modulating Lys(63)-linked polyubiquitination of cytokine-receptor-associated factors including TRAF2/6 (tumour-necrosis-factor-receptor-associated factor 2/6) and RIP] (receptor-interacting protein 1). In the present paper we describe the crystal structure of the N-terminal OTU (ovarian tumour) deubiquitinase domain of A20, which differs from other deubiquitinases but shares the minimal catalytic core with otubain-2. Analysis of conserved surface regions allows prediction of ubiquitin-binding sites for the proximal and distal ubiquitin molecules. Structural and biochemical analysis suggests a novel architecture of the catalytic triad, which might be present in a subset of OTU domains including Cezanne and TRABID (TRAF-binding domain). Biochemical analysis shows a preference of the isolated A20 OTU domain for Lys(48)-linked tetraubiquitin in vitro suggesting that additional specificity factors might be required for the physiological function of A20 in cells.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 33 条
[1]   PHENIX:: building new software for automated crystallographic structure determination [J].
Adams, PD ;
Grosse-Kunstleve, RW ;
Hung, LW ;
Ioerger, TR ;
McCoy, AJ ;
Moriarty, NW ;
Read, RJ ;
Sacchettini, JC ;
Sauter, NK ;
Terwilliger, TC .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1948-1954
[2]   Ubiquitin-mediated activation of TAK1 and IKK [J].
Adhikari, A. ;
Xu, M. ;
Chen, Z. J. .
ONCOGENE, 2007, 26 (22) :3214-3226
[3]   Mechanism and function of deubiquitinating enzymes [J].
Amerik, AY ;
Hochstrasser, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3) :189-207
[4]   A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis [J].
Beyaert, R ;
Heyninck, K ;
Van Huffel, S .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1143-1151
[5]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[6]   Generation, representation and flow of phase information in structure determination:: recent developments in and around SHARP 2.0 [J].
Bricogne, G ;
Vonrhein, C ;
Flensburg, C ;
Schiltz, M ;
Paciorek, W .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 :2023-2030
[7]   Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[8]   Miscellaneous algorithms for density modification [J].
Cowtan, K ;
Main, P .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1998, 54 :487-493
[9]   The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases [J].
De Valck, D ;
Jin, DY ;
Heyninck, K ;
Van de Craen, M ;
Contreras, R ;
Fiers, W ;
Jeang, KT ;
Beyaert, R .
ONCOGENE, 1999, 18 (29) :4182-4190
[10]   A20, an inhibitor of cell death, self-associates by its zinc finger domain [J].
DeValck, D ;
Heyninck, K ;
VanCriekinge, W ;
Contreras, R ;
Beyaert, R ;
Fiers, W .
FEBS LETTERS, 1996, 384 (01) :61-64